Plain-English translation of NCT07236541 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are investigating whether excess mucus in the airways of people with COPD (a chronic lung disease) leads to lung scarring. During lung cancer surgery, they will collect small samples of healthy lung tissue and mucus to study in the laboratory. The goal is to understand how mucus and scarring are connected, which may lead to new treatments.
People with COPD often have thick mucus plugging their airways, which makes breathing harder and can lead to serious infections and complications. Doctors don't yet know if this mucus directly causes permanent scarring in the lungs. This study aims to answer that question and identify new ways to prevent or treat scarring.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will be enrolled as part of either the COPD group or the control group (people without COPD). During your planned lung cancer surgery, the surgeon will collect small samples of healthy lung tissue and any mucus present. These samples will then be analyzed in the laboratory to measure scarring, mucus burden, and specific molecular markers. The study itself involves no additional visits or procedures beyond your standard cancer surgery.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
China